Antibiotics and Bacterial Infections

About the Conference

The 7th Annual Congress on Antibiotics and Bacterial Infections will bring together leading researchers, clinicians, microbiologists, infectious disease specialists, pharmacists, academicians, healthcare professionals, biotechnology experts, pharmaceutical scientists, and public health professionals from around the world.

The congress will provide an international platform to discuss the latest developments in antibiotic research, bacterial pathogenesis, antimicrobial resistance (AMR), infectious disease diagnostics, antimicrobial stewardship, vaccine development, novel therapeutics, and emerging approaches to bacterial infection management.

Antimicrobial resistance continues to challenge the effective prevention and treatment of bacterial infections worldwide. Recent global surveillance data highlight the increasing resistance of important bacterial pathogens to commonly used antibiotics, emphasizing the need for improved diagnostics, responsible antimicrobial use, innovative therapies, and stronger surveillance systems.

The congress will feature keynote presentations, invited lectures, oral presentations, poster sessions, interactive scientific discussions, and networking opportunities, creating an environment for knowledge exchange and international collaboration.

Join Us in Paris

Be part of the 7th Annual Congress on Antibiotics and Bacterial Infections, taking place on January 18–19, 2027, in Paris, France, and contribute to the global scientific dialogue on antibiotic innovation, bacterial infections, and antimicrobial resistance.

Submit your abstract, present your research, connect with international experts, and be part of the future of antibiotic and bacterial infection research.

Conference: 7th Annual Congress on Antibiotics and Bacterial Infections
Date: January 18–19, 2027
Location: Paris, France
Abstract Submission: Open
Presentation: Oral | Poster | E-Poster | Keynote | Young Researcher
Registration: Open

Why Attend?

The 7th Annual Congress on Antibiotics and Bacterial Infections offers an excellent opportunity to:

• Explore the latest advances in antibiotic discovery and development.
• Understand emerging trends in antimicrobial resistance and bacterial pathogens.
• Learn about innovative approaches to diagnosis, prevention, and treatment of bacterial infections.
• Gain insights from leading scientists, clinicians, researchers, and industry professionals.
• Discover advances in antimicrobial stewardship and infection-control practices.
• Discuss novel antibiotics, antimicrobial alternatives, vaccines, bacteriophages, antimicrobial peptides, and host-directed therapies.
• Present your research to an international scientific audience.
• Establish collaborations with researchers, healthcare professionals, universities, biotechnology companies, and pharmaceutical organizations.
• Exchange ideas through keynote lectures, oral presentations, poster sessions, and scientific discussions.
• Explore emerging technologies and research opportunities in microbiology and infectious diseases.
• Expand your professional network and develop new academic and industry collaborations.
• Gain international exposure for your research and scientific achievements

Who Should Attend?

The congress welcomes participation from:

• Microbiologists
• Infectious Disease Specialists
• Clinical Researchers
• Medical Doctors and Physicians
• Pharmacologists and Pharmacists
• Epidemiologists
• Immunologists
• Molecular Biologists
• Biotechnology Professionals
• Pharmaceutical Scientists
• Public Health Professionals
• Biomedical Researchers
• Healthcare Professionals
• Academicians and Professors
• Research Scholars and Students
• Representatives from Pharmaceutical and Biotechnology Industries
• Government and Regulatory Agencies
• Healthcare Organizations
• Diagnostic and Laboratory Professionals

Sessions & Tracks

1. Antibiotic Discovery and Development

This session will explore recent advances in the discovery, design, and development of new antibiotics and antibacterial agents. Topics include novel drug targets, screening approaches, medicinal chemistry, lead optimization, preclinical development, antibiotic pipelines, and strategies for developing effective therapies against resistant bacterial pathogens.

2. Antimicrobial Resistance and Superbugs

This session will focus on the growing challenge of antimicrobial resistance and the emergence of multidrug-resistant, extensively drug-resistant, and difficult-to-treat bacterial pathogens. Discussions will address resistance mechanisms, genetic determinants of resistance, transmission, surveillance, and innovative strategies to prevent and control resistant infections. WHO's current priority pathogen framework highlights the importance of research targeting critical and high-priority resistant bacteria.

3. Bacterial Pathogenesis and Virulence

This track will examine the molecular and cellular mechanisms through which bacteria cause disease. Topics include bacterial virulence factors, toxins, adhesion and invasion, secretion systems, quorum sensing, host-pathogen interactions, immune evasion, bacterial persistence, and mechanisms that contribute to disease severity.

4. Clinical Microbiology and Bacterial Diagnostics

This session will highlight modern approaches to the identification and characterization of bacterial infections. Presentations may cover culture-based methods, molecular diagnostics, rapid pathogen detection, antimicrobial susceptibility testing, point-of-care diagnostics, genomic methods, and laboratory-based surveillance. Rapid and improved diagnostics are recognized as an important area of global AMR research.

5. Antimicrobial Stewardship

This track will address strategies for ensuring the appropriate selection, dosage, duration, and administration of antimicrobial medicines. Topics include hospital and community stewardship programs, antibiotic prescribing practices, pharmacist-led interventions, antimicrobial consumption, clinical decision support, and methods for reducing unnecessary antibiotic exposure while maintaining quality patient care.

6. Novel Antimicrobial Therapies

This session will explore innovative alternatives and complements to conventional antibiotics. Topics include bacteriophage therapy, antimicrobial peptides, bacteriocins, host-directed therapies, antibody-based approaches, combination therapies, microbiome-based strategies, and other emerging antibacterial interventions.

7. Vaccines Against Bacterial Infections

This track will focus on advances in the prevention of bacterial diseases through vaccination. Topics include bacterial vaccine development, antigen discovery, novel vaccine platforms, adjuvants, immunological responses, vaccine effectiveness, vaccine delivery systems, and strategies for preventing infections caused by antibiotic-resistant bacteria.

8. Antimicrobial Peptides and Host Defense

This session will examine naturally occurring and engineered antimicrobial peptides and their potential therapeutic applications. Discussions will include peptide design, mechanisms of bacterial killing, innate immune responses, host-defense molecules, peptide resistance, combination therapies, and the development of antimicrobial peptides as alternatives to traditional antibiotics.

9. Biofilms and Chronic Bacterial Infections

This track will address bacterial biofilms and their important role in persistent and difficult-to-treat infections. Topics include biofilm formation, bacterial persistence, extracellular matrices, biofilm-associated antimicrobial tolerance, chronic infections, medical-device-associated infections, and innovative antibiofilm therapies.

10. One Health and Antimicrobial Resistance

This session will examine AMR as a multidisciplinary challenge connecting human, animal, food, agricultural, and environmental health. Discussions will focus on the movement of resistant organisms and resistance genes across sectors, integrated surveillance, zoonotic transmission, environmental reservoirs, and coordinated One Health interventions. WHO's One Health research framework emphasizes transmission, integrated surveillance, interventions, behavior, economics, and policy.

11. Antibiotics in Agriculture and Food Safety

This track will explore antimicrobial use in livestock, aquaculture, agriculture, and food production. Topics include veterinary antibiotic use, antimicrobial residues, foodborne pathogens, resistance transmission through the food chain, responsible antimicrobial use, and approaches to improve food safety and reduce the development and spread of resistance.

12. Emerging and Re-Emerging Bacterial Infections

This session will discuss newly emerging and re-emerging bacterial pathogens and their implications for global health. Topics include outbreak investigation, epidemiology, pathogen evolution, transmission dynamics, emerging resistance patterns, preparedness, surveillance, and rapid response strategies.

13. Clinical Trials and Therapeutic Advances

This track will focus on the translation of antibacterial discoveries into clinical applications. Topics include clinical trial design, investigational antibiotics, pharmacokinetics and pharmacodynamics, treatment efficacy, safety and tolerability, combination therapies, treatment guidelines, and real-world clinical outcomes.

14. Genomics, Proteomics and Molecular Epidemiology

This session will highlight the application of advanced molecular technologies to bacterial research. Topics include whole-genome sequencing, bacterial genomics, transcriptomics, proteomics, resistome analysis, genomic surveillance, molecular epidemiology, phylogenetics, and bioinformatics approaches for tracking bacterial evolution and antimicrobial resistance.

15. Hospital-Acquired and Healthcare-Associated Infections

This track will address bacterial infections acquired within healthcare settings, including hospitals, long-term care facilities, and other healthcare environments. Topics include infection prevention and control, multidrug-resistant hospital pathogens, antimicrobial-resistant healthcare-associated infections, environmental hygiene, surveillance, outbreak management, and evidence-based prevention strategies.

16. Pediatric and Geriatric Bacterial Infections

This session will focus on bacterial infections among vulnerable age groups, including children and older adults. Topics include age-specific infection patterns, antimicrobial pharmacology, antibiotic dosing, resistant infections, diagnostic challenges, treatment considerations, and strategies for improving clinical outcomes in pediatric and geriatric populations.

17. Sepsis and Severe Bacterial Infections

This track will explore the diagnosis and management of severe bacterial infections and sepsis. Discussions will cover bloodstream infections, rapid pathogen identification, antimicrobial susceptibility testing, early antimicrobial treatment, antimicrobial optimization, critical care, host responses, and approaches for reducing morbidity and mortality.

18. Nanotechnology and Advanced Antibacterial Strategies

This session will examine the application of nanotechnology to bacterial infection prevention and treatment. Topics include nanoparticles with antibacterial activity, nano-enabled drug delivery, targeted antimicrobial systems, antibacterial surfaces and coatings, nanomaterials, nano-antibiotics, and approaches for overcoming bacterial resistance.

19. Microbiome and Bacterial Infection

This track will investigate the relationship between the human microbiome, bacterial communities, and infectious diseases. Topics include microbiome disruption following antibiotic exposure, dysbiosis, host-microbe interactions, microbial ecology, probiotics, microbiome restoration, and microbiome-based strategies for infection prevention and treatment.

20. Public Health, Policy and Global AMR Strategies

This session will examine the public-health and policy dimensions of antimicrobial resistance. Topics include national and international AMR action plans, surveillance systems, antimicrobial access and use, infection prevention, regulatory frameworks, research and development, health-system interventions, public awareness, and global collaboration. WHO's current AMR research agenda emphasizes evidence generation that can translate into practical policies and interventions.

Call for Abstract

Researchers, academicians, clinicians, students, and industry professionals are invited to submit their original research abstracts for presentation at the congress.

Abstracts may address any topic related to antibiotics, bacterial infections, antimicrobial resistance, microbiology, infectious diseases, diagnostics, vaccines, antimicrobial stewardship, novel therapies, or related scientific disciplines.

Presentation Opportunities

• Keynote Presentation

• Oral Presentation

• Poster Presentation

• E-Poster Presentation

• Young Researcher Presentation

• Student Presentation

• Industry Presentation

Abstract Guidelines

Authors are encouraged to submit concise abstracts presenting original research, significant findings, innovative methodologies, clinical studies, reviews, case studies, or emerging scientific developments.

A recommended abstract structure includes:

Title: Clear and concise research title
Background: Scientific rationale and objectives
Methods: Study design and methodology
Results: Major findings and observations
Conclusion: Key outcomes and implications
Keywords: 3–5 relevant keywords

Abstracts should clearly identify the author names, affiliations, country, and corresponding author details.

All submitted abstracts will undergo scientific review. Authors of accepted abstracts will receive an official acceptance notification and presentation details.

Market Analysis

Visa Process

We are committed to ensuring that your participation in Euro Antibiotics 2027 is as smooth and hassle-free as possible.

Our comprehensive visa support package includes:

• Official Invitation Letter: An official invitation from the conference organizers confirming your participation. (The official invitation letter will be provided upon completion of your conference registration and payment.)
• Abstract Acceptance Letter: Confirmation that your abstract has been accepted for presentation at the conference.
• Payment Receipt: Proof of your conference registration and payment.
• Visa Support Letter: A personalized letter outlining the purpose of your visit and the details of your stay in Paris. (The visa support letter will be provided upon completion of your conference registration and payment.)

These essential documents will be sent to you via email in PDF format to ensure quick and secure delivery.

We are dedicated to helping you navigate the visa application process efficiently, allowing you to focus on preparing for the conference. Should you have any questions or require additional assistance, please do not hesitate to contact us.

We look forward to welcoming you to Paris for a productive and enriching conference experience.

You may conveniently complete your payment through Payment Gateway/Stripe or via bank-to-bank transfer. For any inquiries or assistance regarding registration or invoices, please contact us at contact@europeanmeets.com